MarkNtel Advisors recently published a detailed industry analysis of the Global CRISPR Gene Editing Market. The report covers growth trends, geographical marketing strategies, challenges, opportunities, and drivers influencing the market.

Global CRISPR Gene Editing Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2027

The CRISPR Gene Editing Market is projected to grow at a CAGR of around 18.24% during the forecast period, 2022-27.

What are the major Driver the CRISPR Gene Editing industry?

Prevalence of Genetic Disorders & Use of Genome Editing to Boost the Market Growth - The prevalence of genetic disorders has been increasing over the years across the globe. Some of the most prevalent are thalassemia, down syndrome, cystic fibrosis, and sickle cell anemia. For every 10,000 live births globally, 4.4 cases of thalassemia are reported. According to the Thalassemia International Federation, about 7% of the population experience hemoglobin-associated conditions, around 70% have sickle cell anemia, and the remaining develop thalassemia or other blood disorders.

Further, in recent years, CRISPR gene editing demand has been driven by significant breakthrough scientific research across various dimensions to treat hereditary disorders. As per the research publication of the New England Journal of Medicine, 2020, CRISPR gene therapies depicted positive results for treating sickle cell anemia & beta-thalassemia. In addition, ongoing clinical trials for the gene correction in homo sapiens to treat genetic disorders further augmented the growth of the CRISPR Gene Editing market globally. For instance: 

  • Gene Correction in Autologous CD34+ Hematopoietic Stem Cells (HbS to HbA) to Treat Severe Sickle Cell Disease (CEDAR) clinical trial was posted in the USA, as of 2021, which is considered a first-in-human, single-arm study. The study is currently in Phase1/11 & is expected to be completed in 2026.

✅In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecast for years 2025 to 2030, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report.

Access the detailed PDF Sample report –

https://www.marknteladvisors.com/query/request-sample/crispr-gene-editing-market.html

What segments define the Global CRISPR Gene Editing market from 2022 to 2027? How do these segments contribute to market dynamics and growth?

  • By Product Type
    • CRISPR Products
      • Kits & Enzymes
      • Libraries
      • Design Tools
      • Antibodies
      • Others
    • CRISPR Services
      • gRNA Design & Vector Construction
      • Cell Line and Engineering
      • Screening Services
      • Others

According to report, Here, the CRISPR Products type dominates the Global CRISPR Gene Editing market and is anticipated to remain dominant during the forecast period, owing to the presence of CRISPR pooled libraries that consist of thousands of plasmids based on library type, species, and library size.

  • By Application
    • Agriculture
    • Industrial
    • Biomedical
      • Gene Therapy
      • Drug Discovery
      • Diagnostics
    • Others

According to report, Of them all, the biomedical segment held a considerable share in the CRISPR Gene Editing market on account of tremendous development in cell & gene therapy, drug discovery, and diagnostic domains across the globe.

  • By End User
    • Academic Institutions and Research Centers
    • Biotechnology Companies
    • Contract Research Organizations (CROs)
    • Pharmaceutical & Biopharmaceutical Companies

According to report, Among all, Pharmaceutical & Biopharmaceutical companies dominate this segment, followed by biotechnology businesses.

Explore the Complete Global CRISPR Gene Editing Market Analysis Report –

https://www.marknteladvisors.com/research-library/crispr-gene-editing-market.html

Geographical Analysis: Global CRISPR Gene Editing Market

North America

South America

Europe

The Middle East & Africa

Asia-Pacific

Global CRISPR Gene Editing Market Share & Competitive Landscape:

The CRISPR Gene Editing Market is characterized by intense competition, with several key players driving growth through innovation, market expansion, and strategic investments. The competitive landscape provides valuable insights into the industry's leading companies, highlighting their strengths, financial performance, and market influence.

Leading Companies in the Global CRISPR Gene Editing Market are:

  • Abcam Inc.
  • Applied StemCell Inc.
  • Agilent Technologies Inc.
  • Cellecta Inc.
  • CRISPR Therapeutics AG
  • Thermo Fischer Scientific Inc.
  • GeneCopoeia Inc.
  • GeneScript Biotech Corporation
  • Horizon Discovery Group PLC
  • Integrated DNA Technologies Inc.
  • Merck KGaA
  • New England Biolabs, Inc.
  • Origene Technologies Inc.
  • Rockland Immunochemicals Inc.
  • Others (Synthego Corporation, ToolGen Inc., etc.)

Recent Developments by Global CRISPR Gene Editing Market

  • In 2021, Merck KgaA licensed its patented CRISPR-Cas9 technology to Cellecta for the development of next-generation treatments, which enables the researchers to advance treatments for inherited blood disorders, ophthalmologic, and oncological disorders, among others.
  • In 2019, Thermo Fisher Scientific acquired Brammer Bio to increase its presence across the global market with the addition of Brammer Bio for the manufacturing of vectors for cell & gene therapies.

Questions Addressed in this Study

1.What factors are driving the Global CRISPR Gene Editing Market growth?

2.How is the Global CRISPR Gene Editing Market expected to grow over the next five years?

3.What are the key insights into the current trends in the Global CRISPR Gene Editing Market?

4.What is the current size of the Global CRISPR Gene Editing Market, and how is it projected to change in the future?

6.What is the future outlook for the Global CRISPR Gene Editing Market in terms of technological advancements and market expansion?

For a Customized Analysis Report, Just Drop Your Inquiry Here –

https://www.marknteladvisors.com/query/request-customization/crispr-gene-editing-market.html

 Why MarkNtel Advisors?

MarkNtel Advisors is a leading research, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.

Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.

More Research Studies Report:

-Biocomposites Market size was valued at around USD 36.9 billion in 2024 and is projected to reach USD 89 billion by 2030 with a CAGR of around 16%.

-Green Solvents Market size was valued at around USD 1.34 billion in 2024 & is projected to reach USD 1.87 billion by 2030 with a CAGR of around 5.7%.

For Media Inquiries, Please Contact:

Call: +1 628 895 8081 |  +91 120 4278433

Email: sales@marknteladvisors.com

Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511

Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India